Interesting possibility. So J&J fronts the money, but
Interesting possibility. So J&J fronts the money, but takes it off their books? The gal heading up the Med Device business was pretty emphatic that they would be out of Diabetic Care by end of 2018 at the May update meeting. Would J&J be making the investment in hopes of bringing it back into their business if this management team can turn it around? Outside of that, I see no benefit for the overall corporation in making this offer. Maybe I'm missing something, but doesn't seem like a good deal for J&J.
We only have two weeks to wait to see if it materializes or not. If I'm Platinum and realize there is a competing bid outside of my offer, I'd say no to the extension, or the hair cutting begins and the offer goes down $100M per month they delay.
I'm sure we'll see some other potential theories coming out shortly...
1
Decision Diagnostics Corp (DECN) Stock Research Links
Scroll down for more posts ▼
Top 10 Most Recent News Articles
Top 5 Most Recently Viewed Articles
Understanding Investor Sentiment for Dell Technologies Dell Technologies's recent report provides insight into the company's short interest metrics, illustrating a decline of 14.71%. Currently, 17.41 million shares are sold short, which represents about 5.8% of the company's available shares for trading. With an average trading volume indicating it would take 2.78 days to...
Continue Reading
Compass Diversified Investigates Securities Fraud Claims Compass Diversified (NYSE: CODI) is currently facing serious allegations relating to violations in securities laws. An investigation has been initiated to determine the validity of these claims and how they may affect investors. This situation has raised alarms in the investment community as stakeholders seek...
Continue Reading
Understanding the Dow Inc. Class Action Lawsuit Opportunities Investors in Dow Inc. (NYSE: DOW) have a significant opportunity to take action due to a recent class action lawsuit against the company. This legal movement stems from allegations regarding Dow's disclosure practices and possible financial mismanagement. People who purchased or acquired securities within a...
Continue Reading
Overview of the Medical Imaging Reagents Market The medical imaging reagents market is on the verge of significant growth, projected to reach USD 19.31 billion by 2034. This growth, at a compound annual growth rate (CAGR) of 5.1%, reflects the increasing importance of imaging technologies in healthcare. Key Drivers of Market Growth Several factors are driving this...
Continue Reading
GBank Financial Holdings Inc. Welcomes Mike Tyson GBank Financial Holdings Inc. is excited to announce a significant partnership with the legendary Mike Tyson. This strategic collaboration marks a new chapter for GBank, as Tyson steps in as both a strategic investor and promotional partner for the innovative company, BoltBetz. This new partnership aims to revolutionize...
Continue Reading
